STRUCTURE THERAPEUTICS INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is made as of ________, by and between Structure Therapeutics Inc., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Company”), and [Name of Director/Officer] ([US passport/ID]:[*])
April 23, 2021 Melita Sun Jung Email: [***] Re: Amended and Restated Offer of Employment Dear Melita:Structure Therapeutics Inc. • January 12th, 2023 • Pharmaceutical preparations • California
As you know, ShouTi Inc., a Delaware corporation (the “Company”), entered into an employment offer letter with you on February 14, 2021 (the “Offer Letter”). You and the Company hereby agree to amend and restate the Offer Letter. The terms and conditions set forth in this letter agreement (the “Agreement”) shall become effective as of the date hereof, and shall supersede and replace the terms and conditions set forth in the Offer Letter.
EMPLOYMENT CONTRACTEmployment Contract • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations
SHOUTI INC. EXECUTIVE EMPLOYMENT AGREEMENT for RAYMOND STEVENSExecutive Employment Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”), is made and entered into effective as of May 16, 2019 (the “Effective Date”), by and between Raymond Stevens (“Employee”) and ShouTi Inc., a Delaware corporation (the “Company”).
SHANGHAI PREMISES LEASE CONTRACT Important Notice Shanghai Premises Lease ContractShanghai Premises Lease Contract • July 6th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • Shanghai
THIS CONTRACT is made and entered into by and between Party A and Party B, through mutual friendly negotiation based on the principles of equality, voluntariness, fairness and good faith, regarding the lease by Party A to Party B of the real property which Party A is entitled to lease, in accordance with the Contract Law of the People’s Republic of China and the Regulations of Shanghai Municipality for Premises Lease (hereinafter as “Regulations”), with the terms and conditions as follows.
March 2, 2022 Sharon Tetlow Dear Sharon:Structure Therapeutics Inc. • January 12th, 2023 • Pharmaceutical preparations
We are delighted that you have agreed to join the Board of Directors (the “Board”) of ShouTi Inc. (the “Company”) and to serve as the Chair of the Audit Committee of the Board (the “Audit Chair”). This letter sets forth the agreement between you and the Company regarding your Board membership (the “Agreement”):
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • California
This AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (this “First Amendment”) is made and entered into as of December 5, 2022 by and between Structure Therapeutics USA Inc., a Delaware corporation (the “Company”), and Jun Yoon, an individual resident in the State of California (the “Employee”) (the Company and the Employee are hereinafter sometimes individually referred to as a “Party” and together referred to as the “Parties”).
COLLABORATION AGREEMENTCollaboration Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • New York
This Collaboration Agreement (the “Agreement”) is effective as of October 9, 2020 (the “Effective Date”) by and between Schrödinger, LLC, a Delaware limited liability company, having an address of 120 West 45th Street, 17th Floor, New York, New York 10036 (“Schrödinger”), and Lhotse Bio, Inc., a Delaware corporation having an address of 611 Gateway Blvd Suite 223, South San Francisco, CA 94080 (“Lhotse”). Each of Schrödinger and Lhotse may hereinafter be referred to as a “party” to this Agreement or collectively as the “parties”.
November 23, 2022 Joanne Waldstreicher Dear Joanne:Structure Therapeutics Inc. • January 12th, 2023 • Pharmaceutical preparations
We are delighted that you have agreed to join the Board of Directors (the “Board”) of Structure Therapeutics Inc. (the “Company”). This letter sets forth the agreement between you and the Company regarding your Board membership (the “Agreement”):
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • California
THIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of July 30, 2021, by and among ShouTi Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), and the investors set forth in Schedule A attached hereto (each, an “Investor” and collectively, the “Investors”).
Supplemental AgreementSupplemental Agreement • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations
Shanghai Basecamp Biotechnology Co., Ltd. (hereinafter referred to as “Shanghai Basecamp”), a corporation formally organized and validly existing under the laws of the PRC with its address of Room 5-129, No5-123, South Building 1, No. 4560 Jinke Road, China (Shanghai) Pilot Free Trade Zone and legal representative of RAYMOND CHARLES STEVENS;
December 10th, 2021 Daniel Welch Dear Dan:Structure Therapeutics Inc. • January 12th, 2023 • Pharmaceutical preparations
We are delighted that you have agreed to join the Board of Directors (the “Board”) of ShouTi Inc. (the “Company”) and to serve as the Chairman of the Board. This letter sets forth the agreement between you and the Company regarding your Board membership (the “Agreement”):
COLLABORATION AGREEMENTCollaboration Agreement • November 14th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • New York
This Collaboration Agreement (the “Agreement”) is effective as of November 7, 2023 (the “Effective Date”) by and between Schrödinger, Inc., a Delaware corporation having an address of 1540 Broadway, 21st Floor, New York, New York 10036 (“Schrödinger”), and Aconcagua Bio, Inc., a Delaware corporation having an address of 601 Gateway Blvd, Suite 900, South San Francisco, CA 94080 (“Aconcagua”). Each of Schrödinger and Aconcagua may hereinafter be referred to as a “party” to this Agreement or collectively as the “parties”.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 29th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”) is dated as of September 29, 2023, by and among Structure Therapeutics, Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRUCTURE THERAPEUTICS USA INC.Structure Therapeutics Inc. • November 13th, 2024 • Pharmaceutical preparations
Structure Therapeutics USA Inc. (the “Company”) is pleased to offer you continued employment under the terms set forth in this offer letter agreement, which, if accepted, will be effective on September 18, 2024 (the “Start Date”).
STRUCTURE THERAPEUTICS USA INC.Structure Therapeutics Inc. • November 13th, 2024 • Pharmaceutical preparations • California
Structure Therapeutics USA Inc. (the “Company”) is pleased to offer you employment, which is anticipated to begin on September 18, 2024, under the terms set forth in this offer letter employment agreement (the “Agreement”). Your actual employment start date will be referred to herein as the “Start Date”.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • November 17th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”) is dated as of September 29, 2023, by and among Structure Therapeutics, Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
House Leasing ContractHouse Leasing Contract • July 6th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations
Regarding the house leasing matter under this Contract, Party A and Party B have reached the following agreement through friendly negotiation:
EXCHANGE AGREEMENTExchange Agreement • May 11th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations
THIS EXCHANGE AGREEMENT (this “Agreement”) is made as of May 10, 2023, by and among the investors listed on Exhibit A attached hereto (each an “Investor” and together, the “Investors”) and Structure Therapeutics Inc., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Company”).
SUBLEASESublease • July 6th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations
THIS SUBLEASE ("Sublease"), dated as of June 29, 2023, is made by and between Aligos Therapeutics, Inc., a Delaware corporation ("Sublandlord”), and Structure Therapeutics USA Inc., a Delaware corporation ("Subtenant"). Sublandlord and Subtenant hereby agree as follows:
STRUCTURE THERAPEUTICS, INC.Structure Therapeutics Inc. • November 13th, 2024 • Pharmaceutical preparations
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Structure Therapeutics USA, Inc. (f/k/a ShouTi Inc.) (the “Company”) is offering to you to aid in your employment transition.
EMPLOYMENT CONTRACTEmployment Contract • May 9th, 2024 • Structure Therapeutics Inc. • Pharmaceutical preparations
SHANGHAI PREMISES LEASE CONTRACTPremises Lease Contract • January 12th, 2023 • Structure Therapeutics Inc. • Pharmaceutical preparations • Shanghai
THIS CONTRACT is made and entered into by and between Party A and Party B, through mutual friendly negotiation based on the principles of equality, voluntariness, fairness and good faith, regarding the lease by Party A to Party B of the real property which Party A is entitled to lease, in accordance with the Contract Law of the People’s Republic of China and the Regulations of Shanghai Municipality for Premises Lease (hereinafter as “Regulations”), with the terms and conditions as follows.
